'Mi stroke' diaporamas de présentation

Baseline characteristics

Baseline characteristics. Registered 13 655. Not randomised 1 437. Randomised 12 218. Perindopril 6 110. Placebo 6 108. Completed 6 108. Completed 6 107. Patient flow. 141. 176. 57. 115. 134. 130. 2068. 94. 1772. 300. 277. 1251. 197. 2176. 209. 399. 65. 285. 830.

316 views • 20 slides

The TRITON-TIMI 38 Trial is supported by Daiichi Sankyo Co. Ltd. and Eli Lilly and Co.

421 views • 18 slides

The TRITON-TIMI 38 Trial is supported by Daiichi Sankyo Co. Ltd. and Eli Lilly and Co.

399 views • 18 slides

How do we interpret the data?

Hypothesis: baseline risk status of the patients and proximity to a recent cardiovascular event influence the response to dual anti-platelet therapy. Patients with symptomatic CAD, CVD or PAD and all those with a history of CV events were included in this analysis (n=13,434).

246 views • 12 slides

STROKE STATS

STROKE STATS. Third leading cause of death 160 000 deaths a year 731 000 strokes a year 4 400 000 stroke survivors Leading cause of adult disability . Source: Stroke Facts: 1999 NSA. Prevalence of stroke by age and sex United States: 1988-94.

212 views • 7 slides

E CONOMIC B URDEN OF VTE

194 views • 4 slides